Shaad Essa Abedin (@shaadessa) 's Twitter Profile
Shaad Essa Abedin

@shaadessa

Dad, passionate explorer, science enthusiast, practicing physician scientist - developing new treatments - previously at Einstein, UTexas, AZ, & Immunocore

ID: 1438576057

linkhttps://www.linkedin.com/in/shaad-abedin calendar_today18-05-2013 14:37:43

568 Tweet

2,2K Followers

1,1K Following

Science Magazine (@sciencemagazine) 's Twitter Profile Photo

Innate and adaptive immune cells in the central and peripheral nervous systems could offer scientists a treasure trove of clues about the origins of #ParkinsonsDisease and future treatment strategies, argues a new Science Translational Medicine Viewpoint. scim.ag/4WY

Innate and adaptive immune cells in the central and peripheral nervous systems could offer scientists a treasure trove of clues about the origins of #ParkinsonsDisease and future treatment strategies, argues a new <a href="/ScienceTM/">Science Translational Medicine</a> Viewpoint. scim.ag/4WY
Nature Reviews Drug Discovery (@natrevdrugdisc) 's Twitter Profile Photo

FDA approves first tumour-infiltrating lymphocyte therapy, bolstering hopes for cell therapies in solid cancers bit.ly/49b0Q4p Iovance’s lifileucel for patients with melanoma is the result of >30 years of research on this cell therapy modality bit.ly/3NldJQE

FDA approves first tumour-infiltrating lymphocyte therapy, bolstering hopes for cell therapies in solid cancers bit.ly/49b0Q4p

Iovance’s lifileucel for patients with melanoma is the result of &gt;30 years of research on this cell therapy modality bit.ly/3NldJQE
NEJM (@nejm) 's Twitter Profile Photo

Original Article: CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up nej.md/3UMQcMH Editorial: CAR T Cells — A New Horizon for Autoimmunity? nej.md/3wvvxCM #MedTwitter

Original Article: CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up nej.md/3UMQcMH 

Editorial: CAR T Cells — A New Horizon for Autoimmunity? nej.md/3wvvxCM 

#MedTwitter
Montefiore Health System (@montefiorenyc) 's Twitter Profile Photo

We are profoundly grateful that Dr. Ruth Gottesman, Professor Emerita of Pediatrics at Albert Einstein College of Medicine - Official, has made a transformational gift to #MontefioreEinstein—the largest to any medical school in the country—that ensures no student has to pay tuition again. bit.ly/3wvBj7y

NEJM (@nejm) 's Twitter Profile Photo

A novel CAR T-cell therapy directed at EGFRvIII with a secretable EGFR T-cell engager produced rapid responses in three patients with recurrent glioblastoma, but the responses were transient in two of the three. Read the Brief Report for the full study: nej.md/3VnjUIq

A novel CAR T-cell therapy directed at EGFRvIII with a secretable EGFR T-cell engager produced rapid responses in three patients with recurrent glioblastoma, but the responses were transient in two of the three. Read the Brief Report for the full study: nej.md/3VnjUIq
David Gandara (@drgandara) 's Twitter Profile Photo

Hot off the press! “Multi-omics” approach (genomics, epigenomics, proteomics) to plasma testing proves effective in colorectal cancer screening. Hoping same will be seen in other cancer types NEJM ASCO International Society of Liquid Biopsy

Hot off the press! “Multi-omics” approach (genomics, epigenomics, proteomics) to plasma testing proves effective in colorectal cancer screening. Hoping same will be seen in other cancer types <a href="/NEJM/">NEJM</a> <a href="/ASCO/">ASCO</a> <a href="/isliquidbiopsy/">International Society of Liquid Biopsy</a>
Shaad Essa Abedin (@shaadessa) 's Twitter Profile Photo

The TUBB4B gene coding tubulin, had significant association with left-handedness, which indicates that microtubules may be crucial to the human brain asymmetry involved in hand dominance. ⁦nature⁩ nature.com/articles/s4146…

nature (@nature) 's Twitter Profile Photo

A person has received an experimental treatment for the first time that, if successful, will lead them to grow an additional, ‘miniature liver’ go.nature.com/3TSsDQS

Rare Diseases (@checkorphan) 's Twitter Profile Photo

Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL) - For More Visit shorturl.at/k4stq #Leukemia #Acute_Promyelocytic_Leukemia #APL #Quetzal

Quetzal Therapeutics Launches Phase III Clinical Trial of Oral QTX-2101 for Acute Promyelocytic Leukemia (APL) - For More Visit  shorturl.at/k4stq  #Leukemia  #Acute_Promyelocytic_Leukemia  #APL  #Quetzal